Morphabond er and Stools - watery - a phase IV clinical study of FDA data

Summary:

Stools - watery is reported as a side effect among people who take Morphabond er (morphine sulfate), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Ondansetron, and have Multiple myeloma.

The phase IV clinical study analyzes which people have Stools - watery when taking Morphabond er. It is created by eHealthMe based on reports of 312 people who have side effects when taking Morphabond er from the FDA, and is updated regularly.

What is Morphabond er?

Morphabond er has active ingredients of morphine sulfate. eHealthMe is studying from 312 Morphabond er users. Check the latest studies of Morphabond er.

What is Stools - watery?

Stools - watery is found to be associated with 4,646 drugs and 5,941 conditions by eHealthMe. Check the latest studies of Stools - watery.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 27, 2026

312 people reported to have side effects when taking Morphabond er.
Among them, 11 people (3.53%) have Stools - watery.

Could Morphabond er cause Stools - watery?

Among these 11 people:

How long have people been on Morphabond er when they have Stools - watery? *

What is the gender of people who have Stools - watery when taking Morphabond er? *

female: 57.14 %
male: 42.86 %

What is the age of people who have Stools - watery when taking Morphabond er? *

What are other drugs people take besides Morphabond er? *

What are other side effects people have besides Stools - watery? *

Abdominal Pain Upper: 3 people, 27.27%
Headache (pain in head): 3 people, 27.27%
Weakness: 2 people, 18.18%
Thrombocytopenia (decrease of platelets in blood): 2 people, 18.18%
Fatigue (feeling of tiredness): 2 people, 18.18%
White Blood Cell Count Decreased: 1 person, 9.09%
Drowsiness: 1 person, 9.09%
Hypotension (abnormally low blood pressure): 1 person, 9.09%
Hiatal Hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm): 1 person, 9.09%
Heart Rate Irregular: 1 person, 9.09%

What are the existing conditions these people have? *

Multiple Myeloma (cancer of the plasma cells): 3 people, 27.27%
Pain: 1 person, 9.09%
Mantle Cell Lymphoma (cancer of lymphocytes, a type of white blood cell): 1 person, 9.09%
Chronic Kidney Disease: 1 person, 9.09%
Breast Cancer Female: 1 person, 9.09%
Breakthrough Pain: 1 person, 9.09%

* Approximation only. Some reports may have incomplete information.

Do you take Morphabond er and have Stools - watery?

- Check whether Stools - watery is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Morphabond er:

Morphabond er (312 reports)

Stools - watery treatments and more:

Stools - watery (756,291 reports)

Browse all side effects of Morphabond er:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Stools - watery:

Stools - watery (4,646 drugs)

Browse all the conditions that are associated with Stools - watery:

Stools - watery (5,941 conditions)

Related publications that referenced our studies

Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .
Rasmy A, Rahal M, Kisana M, Ahmad S, Salah A, "Morphine induced thrombocytopenia: A case report", Journal of Case Reports and Images in Oncology, 2015 Dec .

How the study uses the data?

The study uses data from the FDA. It is based on morphine sulfate (the active ingredients of Morphabond er) and Morphabond er (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.